Northwest Biotherapeutics, Inc. (NWBO) Financials

NWBO Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 29.3 million 93.6 million
June 30, 2024 28.2 million 86.0 million
March 31, 2024 28.6 million 82.0 million
Dec. 31, 2023 27.9 million 74.9 million

NWBO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -7.5 million 711000
June 30, 2024 -16.7 million 1.1 million
March 31, 2024 -12.6 million 1.2 million
Dec. 31, 2023 -17.4 million 1.6 million

NWBO Net Income

No data available :(

NWBO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 2.9 million 29.3 million -
June 30, 2024 2.9 million 24.8 million 4.5 million
March 31, 2024 2.5 million 14.6 million 4.6 million
Dec. 31, 2023 2.1 million 24.8 million 4.8 million

NWBO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 ?
June 30, 2024 ?
March 31, 2024 ?
Dec. 31, 2023 1.2 billion

NWBO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 760000 8.1 million 7.0 million -
June 30, 2024 521000 8.3 million 9.7 million -516000
March 31, 2024 239000 7.9 million 7.6 million -505000
Dec. 31, 2023 418000 7.5 million 7.7 million -421000

NWBO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 357000 -
June 30, 2024 510000 516000
March 31, 2024 284000 505000
Dec. 31, 2023 445000 421000

NWBO

Price: $0.19

52 week price:
0.18
0.37

Payout Ratio Range:
-2.47%
191.32%

Earnings Per Share: -0.06 USD

P/E Ratio: -3.73

Exchange: OQB

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.3 million

Ebitda: -69.1 million

Market Capitalization: 328.7 million

Links: